Platinum-based chemotherapy agents, comprising cisplatin and oxaliplatin, have demonstrated efficacy in treating a range of malignancies. However, their get more info inherent toxicity necessitates the exploration of alternative or adjunctive therapeutic modalities. Paclitaxel and docetaxel, belongi